|Quantity Discounts||1 - 9999|
|1 - 9999|
Our buyers have spoken – and we’re responding. By popular demand, FDAnews is rebroadcasting this best-selling event from earlier in 2011.
It’s your best opportunity – and last chance – to attend one of our highest-rated events this year.
More than 100 attended this invaluable webinar the first time around. Here’s what one of our satisfied registrants had to say:
“Eugene's easy-going, conversational style of presentation made it more interesting than a dry lecture.”
Gary Buzzell, Regulatory Specialist, Siemens Healthcare
Wrap up your 2011 on a high note … with this special one-time-only encore presentation.
A final rule from the FDA requires devicemakers to begin filing medical device reports electronically.
Once you begin filing electronically, the FDA will expect you to file everything electronically, including: initial reports; supplemental/follow-up reports; file attachments (as PDFs or zips); and source (e.g., user facility) reports.
It’s a learning curve, best climbed early, advises the FDA’s Indira Konduri.
Here’s your opportunity to have an FDA official answer your questions — and more. Read on ...
For devicemakers, a major change looms in dealings with the FDA — the way reports of death and serious injury are filed is to go electronic.
No more paper. No more Excel spreadsheets. You have a lot to learn about eMDR.
Who better to ask for guidance than the FDA?
Mark your calendar for Wednesday, Dec. 7, 2011, when an FDA expert will answer your eMDR questions — all of them.
FDAnews has invited CDER official Eugene Reilly for 90 minutes of discussion and Q&A. And you can join in without ever leaving your desk.
The issue is 21 CFR 803, the rule requiring devicemakers to report serious and fatal events to the FDA. More than 600,000 reports are filed each year.
Two years ago, the FDA proposed switching to electronic filing. Despite criticism of the proposed regulation, the final one shows only minor changes, including the following:
Plan on taking extensive notes as Mr. Reilly covers:
eMDR Conversion and Implementation is convenient to attend. All that’s required is that you be in front of a screen at the appointed time, whether you work at the office or telecommute from your office at home.
Key people throughout your company will benefit from taking part in this event. Best of all, everyone can do so at a cost that won’t break your budget. You pay one single low registration fee per facility, regardless of how many participate. So spread the word.
With implementation mere months off, make sure yourcompany is prepared. Sign up now.
Spread the word throughout your organization. Make particularly sure to notify the following key staff:
Eugene Reilly is a public health analyst in FDA's Center for Devices and Radiological Health Office of Surveillance and Biometrics, specializing in systems that process, display and analyze medical device adverse event information. He also maintains the CDRH Event and Evaluation Codes used in MDRs. He has a background in programming, with expertise in XML, Python, and Java for databases, web-based applications, and computer graphics.
|Date:||Wednesday, Dec. 7, 2011|
|Location:||Your office or conference room (no need to travel!)|
|Time:||1:30 p.m. – 3:00 p.m. EST|
|12:30 p.m. – 2:00 p.m. CST|
|11:30 a.m. – 1:00 p.m. MST|
|10:30 a.m. – 12:00 p.m. PST|
|6:30 p.m. – 8:00 p.m. GMT|
Gather your team for maximum benefit! Your investment is for one dial-in.
Significant tuition discounts are available for three or more sites from
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing